Christopher Contag, the inaugural James and Kathleen Cornelius Endowed Chair, was recruited to MSU to lead the brand-new Institute for Quantitative Health Science and Engineering. A pioneer in molecular imaging, Contag also serves as the Chair of the Department of Biomedical Engineering. His research at MSU will change the way the world thinks about biomedicine through developing new technologies and approaches for precision health and medicine to change how healthcare can be delivered to patients.
Contag graduated from the University of Minnesota with an undergraduate degree in biology and a PhD in microbiology.
Prior to joining MSU, he held many roles at Stanford, including associate chief of Neonatal and Developmental Medicine, director of Stanford’s Center for Innovation in In Vivo Imaging, and co-director of the Molecular Imaging Program. Contag also is a fellow and past president of the World Molecular Imaging Society. His research has been published in a number of journals including Proceedings of the National Academy of Sciences, PloS one and Journal of Biomedical Optics.